Avastin plus chemotherapy for metastatic colorectal cancer increases over time
Results of a recent study demonstrate that the proportion of patients with metastatic colorectal cancer treated with the chemotherapy regimen FOLFOXIRI and Avastin (bevacizumab) increases over time, especially in patients younger than 50 years. . Results of this study were presented at the 2024 ASCO Gastrointestinal Cancer Symposium. FOLFOXIRI is a chemotherapy regimen consisting of […]